Mount Sinai
New York-based Mount Sinai Health System will deploy home-based care and an outpatient rehab program using MindMaze's tools.
New research suggests that the wearable could help identify COVID-19 cases up to seven days before a positive diagnostic test.
Also: Blood glucose monitoring could be coming to next-gen consumer smartwatches; new incubator looking for disruptive health tech startups.
The roughly three-year-old company says it now has a post-money valuation over $1 billion.
Mount Sinai Health System is trying a new way to get high-risk patients to take their medications: financial incentives.
AdhereTech, the New York City-based smart pill bottle company, has begun shipping the generation 2 version of its bottle to pharma and provider customers.
Livongo Health, the diabetes management startup launched last year by former Allscripts CEO Glen Tullman, will roll out its platform to a large group of New Yorkers via the Mount Sinai health system.
The Icahn School of Medicine at Mount Sinai and LifeMap Solutions have updated the asthma app, called Asthma Health, that they created for ResearchKit, Apple's open source platform that helps researchers build medical apps and recruit patients for clinical trials.
New York City and London-based myHealthPal, not to be confused with telehealth product HealthPAL, data platform MyFitnessPal, or Advocate Children's Hospital's app MyHealth Pal, has raised $744,000 (500,000 pounds) in a round led by Andrew MacKay (chairman of Yapp Brothers) and angel investor Will Armitage with participation from Proxy Ventures.